Search - tctmd.com

Displaying 501 - 520 of 831

Sort: Relevancy | Date

Presentation TCT 2016

Hibernating Aneurysm and Ectatic SFA With Large Thrombus Burden Identified Using OCT Guided Atherectomy: Changing Algorithms of Care Using Real-Time Imaging During Therapy

Presenter: Mahmood K. Razavi, Gerald S. Werner, Jaafer Golzar

October 30, 2016

Presentation TCT 2016

Complex Coronary Lesions II: CTO, SVGs

Presenter: Emmanouil S. Brilakis, Kevin J. Croce

October 30, 2016

Presentation TCT 2016

Complex Coronary Lesions I: Left Mains, Bifurcations

Presenter: Goran Stankovic, Tayo A. Addo

October 30, 2016

Presentation TCT 2016

Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments

Presenter: George D. Dangas, Rajesh V Swaminathan

October 30, 2016

Presentation TCT 2016

Current Generation DES and Bioabsorbable Scaffolds

Presenter: Dmitriy N. Feldman, Rajesh V Swaminathan

October 30, 2016

Presentation TCT 2016

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban

October 30, 2016

Presentation TCT 2016

Case Presentations: When OCT Changes Your Strategy in ACS

Presenter: Akiko Maehara, Francesco Prati, Fernando Alfonso

October 30, 2016

Presentation TCT 2016

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

Case Presentations: Just Dont Do it! Lessons From Baseline and Postintervention OCT

Presenter: Akiko Maehara, Francesco Prati

October 30, 2016

Presentation TCT 2016

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Runlin Gao

October 30, 2016

Presentation TCT 2016

Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention and Postintervention Information

Presenter: Akiko Maehara, Francesco Prati, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices

Presenter: Manish A. Parikh, Sahil A. Parikh

October 30, 2016

Presentation TCT 2016

Featured Lecture: The Digital Health Revolution Will Transform Cardiovascular Disease Management in the Future

Presenter: Juan F. Granada, Louis A. Cannon, Peter J. Fitzgerald

October 30, 2016

Presentation TCT 2016

Featured Lecture: Interventional Innovation is Alive and Well Reflections and Predictions

Presenter: Juan F. Granada, Louis A. Cannon, Elazer R. Edelman

October 30, 2016

Presentation TCT 2016

STEMI Treatment Strategies: Drugs and Devices

Presenter: Tayo A. Addo, Dharam J. Kumbhani

October 30, 2016

Presentation TCT 2016

NSTEACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 30, 2016

Presentation TCT 2016

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, David E. Kandzari

October 30, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

Presentation TCT 2016

Stable Angina Decision-making: PCI vs CABG vs OMT

Presenter: Tayo A. Addo, Robert T. Pyo

October 30, 2016

Presentation TCT 2016

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Ziad A. Ali

October 30, 2016

Advertisement

Hibernating Aneurysm and Ectatic SFA With Large Thrombus Burden Identified Using OCT Guided Atherectomy: Changing Algorithms of Care Using Real-Time Imaging During Therapy

Complex Coronary Lesions II: CTO, SVGs

Complex Coronary Lesions I: Left Mains, Bifurcations

Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments

Current Generation DES and Bioabsorbable Scaffolds

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Case Presentations: When OCT Changes Your Strategy in ACS

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: Just Dont Do it! Lessons From Baseline and Postintervention OCT

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention and Postintervention Information

Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices

Featured Lecture: The Digital Health Revolution Will Transform Cardiovascular Disease Management in the Future

Featured Lecture: Interventional Innovation is Alive and Well Reflections and Predictions

STEMI Treatment Strategies: Drugs and Devices

NSTEACS: Risk Stratification and Treatment

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Stable Angina Decision-making: PCI vs CABG vs OMT

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content